Structural and functional insights into IκB-α/HIV-1 Tat interaction

Area of Science:

• Molecular Biology
• Virology
• Structural Biology

Background:

• Protein-protein interactions are crucial in biological processes and disease.
• Understanding these interactions aids in developing therapeutic molecules.
• Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκB-α) inhibits HIV-1 replication via a novel, NF-κB-independent pathway involving direct binding to HIV-1 Tat.

Purpose of the Study:

• To quantify the binding affinity between IκB-α and HIV-1 Tat.
• To identify specific regions of IκB-α responsible for Tat interaction.
• To elucidate the structural basis of IκB-α's interaction with Tat.

Main Methods:

• Surface Plasmon Resonance (SPR) assay to measure binding kinetics.
• Peptide scanning of the IκB-α C-terminus to map interaction sites.
• Mutagenesis studies on full-length IκB-α to confirm residue involvement.

Main Results:

• IκB-α directly binds to HIV-1 Tat with measurable affinity.
• A specific IκB-α peptide (residues 262-287) exhibits high-affinity binding to Tat (KD = 300 nM).
• Mutagenesis reveals distinct IκB-α residues mediate NF-κB versus Tat binding.

Conclusions:

• IκB-α interacts with HIV-1 Tat through its C-terminal region.
• This interaction is independent of the canonical NF-κB pathway.
• The findings offer insights into novel anti-HIV strategies targeting the IκB-α-Tat interaction.